•
Mar 31, 2023

iTeos Therapeutics Q1 2023 Earnings Report

Total Revenue
$12.6M
Previous year: $153M
-91.7%
EPS
-$0.44
Previous year: $1.82
-124.2%
Gross Profit
$12.4M
Previous year: $152M
-91.9%
Cash and Equivalents
$225M
Previous year: $824M
-72.6%
Free Cash Flow
-$26.7M
Previous year: -$24.2M
+10.1%
Total Assets
$728M
Previous year: $850M
-14.3%

iTeos Therapeutics

iTeos Therapeutics